| Page | ||||||||
| Consolidated Financial Highlights | ||||||||
| Summary Consolidated Balance Sheets | ||||||||
| Summary Consolidated Income Statements | ||||||||
Return on Equity | ||||||||
Combined Ratios | ||||||||
| Roll-forward of Unpaid Losses and LAE | ||||||||
| Consolidated Investment Portfolio | ||||||||
| Book Value Per Share | ||||||||
| Earnings Per Share | ||||||||
| Non-GAAP Financial Measures | ||||||||
| Three Months Ended | |||||||||||||||||
| March 31, | |||||||||||||||||
| 2025 | 2024 | % change | |||||||||||||||
| Selected financial highlights: | |||||||||||||||||
| Gross premiums written | $ | 212.1 | $ | 210.9 | 1 | % | |||||||||||
| Net premiums written | 210.3 | 209.1 | 1 | ||||||||||||||
| Net premiums earned | 183.0 | 184.9 | (1) | ||||||||||||||
| Net investment income | 32.1 | 26.8 | 20 | ||||||||||||||
Net income excluding LPT(1) | 11.2 | 26.2 | (57) | ||||||||||||||
Adjusted net income(1) | 21.3 | 17.2 | 24 | ||||||||||||||
| Net Income before income taxes | 15.9 | 35.3 | (55) | ||||||||||||||
| Net Income | 12.8 | 28.3 | (55) | ||||||||||||||
| Comprehensive income | 34.6 | 17.4 | 99 | ||||||||||||||
| Total assets | 3,556.9 | 3,562.8 | — | ||||||||||||||
| Stockholders' equity | 1,075.7 | 1,018.9 | 6 | ||||||||||||||
Stockholders' equity including the Deferred Gain(2) | 1,168.1 | 1,116.1 | 5 | ||||||||||||||
Adjusted stockholders' equity(2) | 1,228.8 | 1,213.0 | 1 | ||||||||||||||
Annualized adjusted return on stockholders' equity(3) | 6.9 | % | 5.7 | % | 21 | % | |||||||||||
| Amounts per share: | |||||||||||||||||
| Cash dividends declared per share | $ | 0.30 | $ | 0.28 | 7 | % | |||||||||||
Earnings per diluted share(4) | 0.52 | 1.11 | (53) | ||||||||||||||
Earnings per diluted share excluding LPT(4) | 0.46 | 1.03 | (55) | ||||||||||||||
Adjusted earnings per diluted share(4) | 0.87 | 0.67 | 30 | ||||||||||||||
Book value per share(2) | 44.43 | 40.20 | 11 | ||||||||||||||
Book value per share including the Deferred Gain(2) | 48.25 | 44.04 | 10 | ||||||||||||||
Adjusted book value per share(2) | 50.75 | 47.86 | 6 | ||||||||||||||
Combined ratio excluding LPT:(5): | |||||||||||||||||
Loss and loss adjustment expense ratio: | |||||||||||||||||
Current Year | 66.1 | % | 64.2 | % | |||||||||||||
Prior Year | 0.7 | (0.1) | |||||||||||||||
Loss and loss adjustment expense ratio | 66.8 | % | 64.1 | % | |||||||||||||
Commission expense ratio | 12.6 | % | 13.6 | % | |||||||||||||
| Underwriting expense ratio | 23.4 | % | 25.0 | % | |||||||||||||
Combined ratio excluding LPT | 102.8 | % | 102.7 | % | |||||||||||||
| (1) See Page 3 for calculations and Page 10 for information regarding our use of Non-GAAP Financial Measures. | |||||||||||||||||
(2) See Page 8 for calculations and Page 10 for information regarding our use of Non-GAAP Financial Measures. | |||||||||||||||||
| (3) See Page 4 for calculations and Page 10 for information regarding our use of Non-GAAP Financial Measures. | |||||||||||||||||
| (4) See Page 9 for description and calculations and Page 10 for information regarding our use of Non-GAAP Financial Measures. | |||||||||||||||||
| (5) See Pages 5 for details and Page 10 for information regarding our use of Non-GAAP Financial Measures. | |||||||||||||||||
| March 31, 2025 | December 31, 2024 | |||||||||||||
| ASSETS | ||||||||||||||
| Investments, cash and cash equivalents | $ | 2,537.6 | $ | 2,532.4 | ||||||||||
| Accrued investment income | 14.6 | 15.7 | ||||||||||||
Premiums receivable, net | 377.0 | 361.3 | ||||||||||||
| Reinsurance recoverable, net of allowance, on paid and unpaid losses and LAE | 412.9 | 417.8 | ||||||||||||
| Deferred policy acquisition costs | 63.8 | 59.6 | ||||||||||||
| Deferred income tax asset, net | 35.0 | 38.3 | ||||||||||||
| Other assets | 116.0 | 116.2 | ||||||||||||
| Total assets | $ | 3,556.9 | $ | 3,541.3 | ||||||||||
| LIABILITIES | ||||||||||||||
| Unpaid losses and LAE | $ | 1,792.6 | $ | 1,808.2 | ||||||||||
| Unearned premiums | 428.0 | 402.2 | ||||||||||||
| Commissions and premium taxes payable | 60.3 | 65.8 | ||||||||||||
| Deferred Gain | 92.4 | 94.0 | ||||||||||||
| Other liabilities | 107.9 | 102.4 | ||||||||||||
| Total liabilities | $ | 2,481.2 | $ | 2,472.6 | ||||||||||
| STOCKHOLDERS' EQUITY | ||||||||||||||
| Common stock and additional paid-in capital | $ | 424.7 | $ | 424.8 | ||||||||||
| Retained earnings | 1,478.5 | 1,472.9 | ||||||||||||
| Accumulated other comprehensive loss | (60.7) | (82.5) | ||||||||||||
Treasury stock, at cost | (766.8) | (746.5) | ||||||||||||
| Total stockholders’ equity | 1,075.7 | 1,068.7 | ||||||||||||
| Total liabilities and stockholders’ equity | $ | 3,556.9 | $ | 3,541.3 | ||||||||||
Stockholders' equity including the Deferred Gain (1) | $ | 1,168.1 | $ | 1,162.7 | ||||||||||
Adjusted stockholders' equity (1) | 1,228.8 | 1,245.2 | ||||||||||||
Book value per share (1) | $ | 44.43 | $ | 43.52 | ||||||||||
Book value per share including the Deferred Gain(1) | 48.25 | 47.35 | ||||||||||||
Adjusted book value per share (1) | 50.75 | 50.71 | ||||||||||||
(1) See Page 8 for calculations and Page 10 for information regarding our use of Non-GAAP Financial Measures. | ||||||||||||||
| Three Months Ended | |||||||||||
| March 31, | |||||||||||
| 2025 | 2024 | ||||||||||
| Revenues: | |||||||||||
| Net premiums earned | $ | 183.0 | $ | 184.9 | |||||||
| Net investment income | 32.1 | 26.8 | |||||||||
Net realized and unrealized (losses) gains on investments(1) | (12.8) | 11.4 | |||||||||
| Other income | 0.3 | — | |||||||||
| Total revenues | 202.6 | 223.1 | |||||||||
| Expenses: | |||||||||||
| Losses and LAE incurred | (120.7) | (116.5) | |||||||||
| Commission expense | (23.0) | (25.1) | |||||||||
| Underwriting expenses | (42.9) | (46.2) | |||||||||
| Interest and financing expenses | (0.1) | — | |||||||||
| Total expenses | (186.7) | (187.8) | |||||||||
Net income before income taxes | 15.9 | 35.3 | |||||||||
Income tax expense | (3.1) | (7.0) | |||||||||
| Net Income | 12.8 | 28.3 | |||||||||
Unrealized AFS investment gains (losses) arising during the period, net of tax(2) | 21.1 | (11.6) | |||||||||
Reclassification adjustment for net realized AFS investment losses in net income, net of tax(2) | 0.7 | 0.7 | |||||||||
| Total comprehensive income | $ | 34.6 | $ | 17.4 | |||||||
| Net Income | $ | 12.8 | $ | 28.3 | |||||||
| Amortization of the Deferred Gain - losses | (1.6) | (1.5) | |||||||||
| Amortization of the Deferred Gain - contingent commission | — | (0.4) | |||||||||
| LPT contingent commission adjustments | — | (0.2) | |||||||||
Net income excluding LPT Agreement (3) | 11.2 | 26.2 | |||||||||
| Net realized and unrealized losses (gains) on investments | 12.8 | (11.4) | |||||||||
| Income tax (benefit) expense related to items excluded from Net income | (2.7) | 2.4 | |||||||||
| Adjusted net income | $ | 21.3 | $ | 17.2 | |||||||
(1) Includes unrealized (losses) gains on equity securities and other investments of $(11.7) million and $12.7 million for the three months ended March 31, 2025 and 2024, respectively. | |||||||||||
| (2) AFS = Available for Sale securities. | |||||||||||
(3) See Page 10 regarding our use of Non-GAAP Financial Measures. | |||||||||||
| Three Months Ended | ||||||||||||||
| March 31, | ||||||||||||||
| 2025 | 2024 | |||||||||||||
Net income | A | $ | 12.8 | $ | 28.3 | |||||||||
| Impact of the LPT Agreement | (1.6) | (2.1) | ||||||||||||
| Net realized and unrealized losses (gains) on investments | 12.8 | (11.4) | ||||||||||||
| Income tax (benefit) expense related to items excluded from Net income | (2.7) | 2.4 | ||||||||||||
Adjusted net income (1) | B | 21.3 | 17.2 | |||||||||||
| Stockholders' equity - end of period | $ | 1,075.7 | $ | 1,018.9 | ||||||||||
| Stockholders' equity - beginning of period | 1,068.7 | 1,013.9 | ||||||||||||
| Average stockholders' equity | C | 1,072.2 | 1,016.4 | |||||||||||
| Stockholders' equity - end of period | $ | 1,075.7 | $ | 1,018.9 | ||||||||||
| Deferred Gain - end of period | 92.4 | 97.2 | ||||||||||||
| Accumulated other comprehensive loss - end of period | 76.8 | 122.6 | ||||||||||||
| Income taxes related to accumulated other comprehensive loss - end of period | (16.1) | (25.7) | ||||||||||||
| Adjusted stockholders' equity - end of period | 1,228.8 | 1,213.0 | ||||||||||||
| Adjusted stockholders' equity - beginning of period | 1,245.2 | 1,199.1 | ||||||||||||
Average adjusted stockholders' equity (1) | D | 1,237.0 | 1,206.1 | |||||||||||
| Return on stockholders' equity | A / C | 1.2 | % | 2.8 | % | |||||||||
| Annualized return on stockholders' equity | 4.8 | 11.1 | ||||||||||||
Adjusted return on stockholders' equity (1) | B / D | 1.7 | % | 1.4 | % | |||||||||
Annualized adjusted return on stockholders' equity (1) | 6.9 | 5.7 | ||||||||||||
(1) See Page 10 for information regarding our use of Non-GAAP Financial Measures. | ||||||||||||||
| Three Months Ended | ||||||||||||||
| March 31, | ||||||||||||||
| 2025 | 2024 | |||||||||||||
Net premiums earned | A | $ | 183.0 | $ | 184.9 | |||||||||
Losses and LAE incurred | B | 120.7 | 116.5 | |||||||||||
Amortization of deferred reinsurance gain - losses | 1.6 | 1.5 | ||||||||||||
Amortization of deferred reinsurance gain - contingent commission | — | 0.4 | ||||||||||||
LPT contingent commission adjustments | — | 0.2 | ||||||||||||
Losses and LAE excluding LPT(1) | C | 122.3 | 118.6 | |||||||||||
| Prior year loss reserve development | 1.3 | (0.1) | ||||||||||||
Losses and LAE excluding LPT - current accident year | D | $ | 121.0 | $ | 118.7 | |||||||||
Commission expense | E | $ | 23.0 | $ | 25.1 | |||||||||
| Underwriting expenses | F | $ | 42.9 | $ | 46.2 | |||||||||
GAAP combined ratio: | ||||||||||||||
Loss and LAE ratio | B/A | 66.0 | % | 63.0 | % | |||||||||
Commission expense ratio | E/A | 12.6 | 13.6 | |||||||||||
| Underwriting expense ratio | F/A | 23.4 | 25.0 | |||||||||||
GAAP combined ratio | 102.0 | % | 101.6 | % | ||||||||||
Combined ratio excluding LPT:(1) | ||||||||||||||
Loss and LAE ratio excluding LPT | C/A | 66.8 | % | 64.1 | % | |||||||||
Commission expense ratio | E/A | 12.6 | 13.6 | |||||||||||
| Underwriting expense ratio | F/A | 23.4 | 25.0 | |||||||||||
Combined ratio excluding LPT | 102.8 | % | 102.7 | % | ||||||||||
Combined ratio excluding LPT: current accident year:(1) | ||||||||||||||
Loss and LAE ratio excluding LPT | D/A | 66.1 | % | 64.2 | % | |||||||||
Commission expense ratio | E/A | 12.6 | 13.6 | |||||||||||
| Underwriting expense ratio | F/A | 23.4 | 25.0 | |||||||||||
Combined ratio excluding LPT: current accident year | 102.1 | % | 102.8 | % | ||||||||||
(1) See Page 10 for information regarding our use of Non-GAAP Financial Measures. | ||||||||||||||
| Three Months Ended | |||||||||||
| March 31, | |||||||||||
| 2025 | 2024 | ||||||||||
| Unpaid losses and LAE at beginning of period | $ | 1,808.2 | $ | 1,884.5 | |||||||
| Reinsurance recoverable, excluding CECL allowance, on unpaid losses and LAE | 412.4 | 428.4 | |||||||||
| Net unpaid losses and LAE at beginning of period | 1,395.8 | 1,456.1 | |||||||||
| Losses and LAE incurred: | |||||||||||
| Current year losses | 121.0 | 118.7 | |||||||||
| Prior year losses | 1.3 | (0.1) | |||||||||
| Total losses incurred | 122.3 | 118.6 | |||||||||
| Losses and LAE paid: | |||||||||||
| Current year losses | 8.0 | 6.8 | |||||||||
| Prior year losses | 124.6 | 117.4 | |||||||||
| Total paid losses | 132.6 | 124.2 | |||||||||
| Net unpaid losses and LAE at end of period | 1,385.5 | 1,450.5 | |||||||||
| Reinsurance recoverable, excluding CECL allowance, on unpaid losses and LAE | 407.1 | 424.0 | |||||||||
| Unpaid losses and LAE at end of period | $ | 1,792.6 | $ | 1,874.5 | |||||||
| March 31, 2025 | December 31, 2024 | |||||||||||||||||||||||||||||||||||||
| Investment Positions: | Cost or Amortized Cost (1) | Net Unrealized Gain (Loss) | Fair Value | % | Fair Value | % | ||||||||||||||||||||||||||||||||
| Fixed maturity securities | $ | 2,165.7 | $ | (76.9) | $ | 2,087.4 | 82 | % | $ | 2,097.4 | 83 | % | ||||||||||||||||||||||||||
| Equity securities | 151.4 | 102.7 | 254.2 | 10 | 259.8 | 10 | ||||||||||||||||||||||||||||||||
| Short-term investments | — | — | — | — | 0.1 | — | ||||||||||||||||||||||||||||||||
| Other invested assets | 85.0 | 10.4 | 95.4 | 4 | 106.6 | 4 | ||||||||||||||||||||||||||||||||
| Cash and cash equivalents | 100.4 | — | 100.4 | 4 | 68.3 | 3 | ||||||||||||||||||||||||||||||||
| Restricted cash and cash equivalents | 0.2 | — | 0.2 | — | 0.2 | — | ||||||||||||||||||||||||||||||||
| Total investments and cash | $ | 2,502.7 | $ | 36.2 | $ | 2,537.6 | 100 | % | $ | 2,532.4 | 100 | % | ||||||||||||||||||||||||||
| Breakout of Fixed Maturity Securities: | ||||||||||||||||||||||||||||||||||||||
| U.S. Treasuries and agencies | $ | 68.0 | $ | (0.9) | $ | 67.1 | 3 | % | $ | 59.3 | 3 | % | ||||||||||||||||||||||||||
| States and municipalities | 161.3 | (1.6) | 159.7 | 8 | 159.3 | 8 | ||||||||||||||||||||||||||||||||
| Corporate securities | 821.8 | (33.6) | 788.0 | 38 | 803.0 | 38 | ||||||||||||||||||||||||||||||||
| Mortgage-backed securities | 727.1 | (36.8) | 689.9 | 33 | 684.9 | 33 | ||||||||||||||||||||||||||||||||
| Asset-backed securities | 212.3 | — | 212.3 | 10 | 214.0 | 10 | ||||||||||||||||||||||||||||||||
| Collateralized loan obligations | 26.4 | (0.2) | 26.2 | 1 | 35.3 | 2 | ||||||||||||||||||||||||||||||||
| Bank loans and other | 148.8 | (3.8) | 144.2 | 7 | 141.6 | 7 | ||||||||||||||||||||||||||||||||
| Total fixed maturity securities | $ | 2,165.7 | $ | (76.9) | $ | 2,087.4 | 100 | % | $ | 2,097.4 | 100 | % | ||||||||||||||||||||||||||
| Weighted average book yield | 4.5% | 4.5% | |||||||||||||||||||||
| Average credit quality (S&P) | A+ | A+ | |||||||||||||||||||||
| Duration | 4.3 | 4.5 | |||||||||||||||||||||
(1) Amortized cost excludes allowance for current expected credit losses of $1.4 million. | |||||||||||||||||||||||
| March 31, 2025 | December 31, 2024 | March 31, 2024 | December 31, 2023 | |||||||||||||||||||||||
| Numerators: | ||||||||||||||||||||||||||
| Stockholders' equity | A | $ | 1,075.7 | $ | 1,068.7 | $ | 1,018.9 | $ | 1,013.9 | |||||||||||||||||
| Plus: Deferred Gain | 92.4 | 94.0 | 97.2 | 99.2 | ||||||||||||||||||||||
Stockholders' equity including the Deferred Gain (1) | B | 1,168.1 | 1,162.7 | 1,116.1 | 1,113.1 | |||||||||||||||||||||
| Accumulated other comprehensive loss | 76.8 | 104.5 | 122.6 | 108.9 | ||||||||||||||||||||||
| Income taxes related to accumulated other comprehensive loss | (16.1) | (22.0) | (25.7) | (22.9) | ||||||||||||||||||||||
Adjusted stockholders' equity (1) | C | $ | 1,228.8 | $ | 1,245.2 | $ | 1,213.0 | $ | 1,199.1 | |||||||||||||||||
| Denominator (shares outstanding) | D | 24,210,602 | 24,556,706 | 25,343,504 | 25,369,753 | |||||||||||||||||||||
Book value per share (1) | A / D | $ | 44.43 | $ | 43.52 | $ | 40.20 | $ | 39.96 | |||||||||||||||||
Book value per share including the Deferred Gain(1) | B / D | 48.25 | 47.35 | 44.04 | 43.88 | |||||||||||||||||||||
Adjusted book value per share (1) | C / D | 50.75 | 50.71 | 47.86 | 47.26 | |||||||||||||||||||||
Year-over-year change in: (2) | ||||||||||||||||||||||||||
| Book value per share | 13.5 | % | 11.9 | % | 14.5 | % | 18.1 | % | ||||||||||||||||||
| Book value per share including the Deferred Gain | 12.3 | 10.6 | 13.1 | 16.3 | ||||||||||||||||||||||
| Adjusted book value per share | 8.5 | 9.8 | 10.8 | 10.5 | ||||||||||||||||||||||
(1) See Page 10 for information regarding our use of Non-GAAP Financial Measures. | ||||||||||||||||||||||||||
(2) Reflects the twelve month change in book value per share after taking into account dividends declared of $1.20, $1.18, $1.12 and $1.10 for the twelve month periods ended March 31, 2025, December 31, 2024, March 31, 2024 and December 31, 2023, respectively. | ||||||||||||||||||||||||||
| Three Months Ended | ||||||||||||||
| March 31, | ||||||||||||||
| 2025 | 2024 | |||||||||||||
| Numerators: | ||||||||||||||
Net income | A | $ | 12.8 | $ | 28.3 | |||||||||
| Impact of the LPT Agreement | (1.6) | (2.1) | ||||||||||||
Net income excluding LPT (1) | B | 11.2 | 26.2 | |||||||||||
| Net realized and unrealized losses (gains) on investments | 12.8 | (11.4) | ||||||||||||
| Income tax (benefit) expense related to items excluded from Net income | (2.7) | 2.4 | ||||||||||||
Adjusted net income (1) | C | $ | 21.3 | $ | 17.2 | |||||||||
| Denominators: | ||||||||||||||
| Average common shares outstanding (basic) | D | 24,398,610 | 25,345,942 | |||||||||||
| Average common shares outstanding (diluted) | E | 24,606,572 | 25,535,971 | |||||||||||
Earnings per share: | ||||||||||||||
| Basic | A / D | $ | 0.52 | $ | 1.12 | |||||||||
Diluted | A / E | 0.52 | 1.11 | |||||||||||
Earnings per share excluding LPT: (1) | ||||||||||||||
| Basic | B / D | $ | 0.46 | $ | 1.03 | |||||||||
Diluted | B / E | 0.46 | 1.03 | |||||||||||
Adjusted earnings per share: (1) | ||||||||||||||
| Basic | C / D | $ | 0.87 | $ | 0.68 | |||||||||
| Diluted | C / E | 0.87 | 0.67 | |||||||||||
(1) See Page 10 for information regarding our use of Non-GAAP Financial Measures. | ||||||||||||||